NEWS: Nature: Tapping into the drug discovery potential of AI

Written by Guest User
2560px-Nature_journal_logo.svg.png

Our partnership with Janssen of The Johnson and Johnson Pharmaceutical Companies and Sema4, to predict the onset and severity of COVID-19 among different patient populations, is highlighted in a Nature article on the growing field of AI-powered drug discovery.

To read the article click here: https://www.nature.com/articles/d43747-021-00045-7

Guest User
Previous

PRESS RELEASE: BioSymetrics Expands Leadership Team to Support Rapid Growth
Next

Binary Classification Metrics